Guidance
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Published guidance on this topic (12)
- New guidance in the last 6 months (5)
- Updated guidance in the last 6 months (0)
- In development guidance (4)
NICE advice
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (1)
- New advice in the last 6 months (0)
- Updated advice in the last 6 months (0)
- In development advice (0)
Quality standards
Set out priority areas for quality improvement in health and social care.
Published quality standards on this topic (1)
- New quality standards in the last 6 months (1)
- Updated quality standards in the last 6 months (0)
- In development quality standards (1)
NICE Pathways
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject.
Guidance by programme
-
NICE guidelines (2)
Review the evidence across broad health and social care topics.
-
Technology appraisal guidance (6)
Reviews the clinical and cost-effectiveness of new treatments.
-
Interventional procedures guidance (7)
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
-
Medical technologies guidance (1)
Reviews new medical devices for adoption in the NHS.
Advice by programme
-
Evidence summaries (1)
Review the best available evidence for selected medicines.
Products being developed or updated
-
In consultation (1)
Guidance and quality standards open for consultation.
-
In development (5)
Guidance, quality standards and advice being developed.
Get involved
Comment on guidance in development
Current guidance in consultation
News on this topic
New NICE guideline will help doctors recognise and refer people with suspected neurological conditions
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
New migraine drug not cost-effective NICE says in draft guidance
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
Putting guidance into practice
Shared learning
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 1 of 1 shared learning examples for this topic: